beatandraise : Equity Research with AI and ChatGPT on SEC Edgar

beatandraise.com

beta

Palantir Technologies Inc.

Statements

Exhibits

pltr-20240930.htm a2020equityincentiveplan20.htm a2024q3exhibit311.htm a2024q3exhibit312.htm a2024q3exhibit321.htm

about terms

beatandraise.com

beta

Palantir Technologies Inc.

Statements

Exhibits

pltr-20240930.htm a2020equityincentiveplan20.htm a2024q3exhibit311.htm a2024q3exhibit312.htm a2024q3exhibit321.htm

about terms

Condensed Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Income Statement [Abstract]
Revenue	$ 725,516	$ 558,159	$ 2,037,988	$ 1,616,662
Cost of revenue	146,639	107,922	391,457	322,466
Gross profit	578,877	450,237	1,646,531	1,294,196
Operating expenses:
Sales and marketing	209,474	176,373	599,460	547,629
Research and development	117,555	105,708	336,376	295,341
General and administrative	138,708	128,173	411,335	397,054
Total operating expenses	465,737	410,254	1,347,171	1,240,024
Income from operations	113,140	39,983	299,360	54,172
Interest income	52,120	36,864	142,065	88,027
Other income (expense), net	(8,110)	3,122	(32,790)	(11,355)
Income before provision for income taxes	157,150	79,969	408,635	130,844
Provision for income taxes	7,809	6,530	17,653	10,382
Net income	149,341	73,439	390,982	120,462
Less: Net income attributable to noncontrolling interests	5,816	1,934	7,801	4,028
Net income attributable to common stockholders	$ 143,525	$ 71,505	$ 383,181	$ 116,434
Net earnings per share attributable to common stockholders, basic (in dollars per share)	$ 0.06	$ 0.03	$ 0.17	$ 0.05
Net earnings per share attributable to common stockholders, diluted (in dollars per share)	$ 0.06	$ 0.03	$ 0.16	$ 0.05
Weighted-average shares of common stock outstanding used in computing net earnings per share attributable to common stockholders, basic (in shares)	2,250,032,000	2,162,530,000	2,231,790,000	2,134,045,000
Weighted-average shares of common stock outstanding used in computing net earnings per share attributable to common stockholders, diluted (in shares)	2,459,589,000	2,325,600,000	2,424,864,000	2,281,347,000

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Operating activities
Net income	$ 390,982	$ 120,462
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	24,581	25,382
Stock-based compensation	409,840	343,295
Noncash operating lease expense	32,041	34,810
Unrealized and realized (gain) loss from marketable securities, net	26,021	11,810
Noncash consideration	(34,789)	(34,852)
Other operating activities	19,115	(13,328)
Changes in operating assets and liabilities:
Accounts receivable, net	(311,699)	(159,752)
Prepaid expenses and other current assets	(19,547)	(75)
Other assets	4,056	1,941
Accounts payable	7,710	(32,387)
Accrued liabilities	42,149	2,552
Deferred revenue, current and noncurrent	(27,117)	64,464
Customer deposits, current and noncurrent	159,457	84,272
Operating lease liabilities, current and noncurrent	(35,205)	(37,767)
Other noncurrent liabilities	5,943	184
Net cash provided by operating activities	693,538	411,011
Investing activities
Purchases of property and equipment	(9,528)	(10,254)
Purchases of marketable securities	(3,418,699)	(4,791,670)
Proceeds from sales and redemption of marketable securities	2,451,378	2,608,898
Proceeds from sales of alternative investments	0	51,072
Other investing activities	4,000	0
Net cash used in investing activities	(980,849)	(2,141,954)
Financing activities
Proceeds from the exercise of common stock options	270,207	166,829
Repurchases of common stock	45,598	0
Other financing activities	91	778
Net cash provided by financing activities	224,700	167,607
Effect of foreign exchange on cash, cash equivalents, and restricted cash	960	(2,113)
Net decrease in cash, cash equivalents, and restricted cash	(61,651)	(1,565,449)
Cash, cash equivalents, and restricted cash - beginning of period	850,107	2,627,335
Cash, cash equivalents, and restricted cash - end of period	$ 788,456	$ 1,061,886

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 768,710	$ 831,047
Marketable securities	3,795,949	2,843,132
Accounts receivable, net	668,110	364,784
Prepaid expenses and other current assets	119,193	99,655
Total current assets	5,351,962	4,138,618
Property and equipment, net	40,345	47,758
Operating lease right-of-use assets	211,570	182,863
Other assets	164,220	153,186
Total assets	5,768,097	4,522,425
Current liabilities:
Accounts payable	27,021	12,122
Accrued liabilities	265,244	222,991
Deferred revenue	236,608	246,901
Customer deposits	366,946	209,828
Operating lease liabilities	47,637	54,176
Total current liabilities	943,456	746,018
Deferred revenue, noncurrent	7,825	28,047
Customer deposits, noncurrent	3,681	1,477
Operating lease liabilities, noncurrent	207,278	175,216
Other noncurrent liabilities	14,495	10,702
Total liabilities	1,176,735	961,460
Commitments and Contingencies (Note 7)
Stockholders’ equity:
Common stock	2,270	2,200
Additional paid-in capital	9,757,380	9,122,173
Accumulated other comprehensive income, net	4,925	801
Accumulated deficit	(5,266,432)	(5,649,613)
Total stockholders’ equity	4,498,143	3,475,561
Noncontrolling interests	93,219	85,404
Total equity	4,591,362	3,560,965
Total liabilities and equity	$ 5,768,097	$ 4,522,425